Adrenal Corticosteroid Inhibitors Market
Adrenal corticosteroid inhibitors are a class of therapeutic drugs that are widely used to treat ... Read More
Patient-derived xenografts (PDX) are a model of cancer in which tissues or cells from a patient's tumor are implanted in immunodeficient or humanized mice. The PDX model is used to create an environment that allows the cancer to grow naturally, monitor and evaluate the original patient's treatment accordingly.
This report contains market size and forecasts of PDX Models in Global, including the following market information:
Global PDX Models Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global PDX Models market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Mice Models Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of PDX Models include Charles River, Crown Bioscience, Champion Oncology, The Jackson Laboratory, Oncodesign, Wuxi Apptec, Horizon Discovery Group, Pharmatest Services and MI Bioresearch, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the PDX Models companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PDX Models Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global PDX Models Market Segment Percentages, by Type, 2021 (%)
Mice Models
Rat Models
Global PDX Models Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global PDX Models Market Segment Percentages, by Application, 2021 (%)
Preclinical Drug Development and Oncology Research
Biomarker Analysis
Global PDX Models Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global PDX Models Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies PDX Models revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies PDX Models revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Charles River
Crown Bioscience
Champion Oncology
The Jackson Laboratory
Oncodesign
Wuxi Apptec
Horizon Discovery Group
Pharmatest Services
MI Bioresearch
Creative Animodel
Urosphere
Xentech
Hera BioLabs
EPO Berlin-Buch
Adrenal corticosteroid inhibitors are a class of therapeutic drugs that are widely used to treat ... Read More
Increasing incidence of bone and joint diseases, the increase in the global obese population, the ... Read More
Shoes that are made strictly for walking usually have more of an arch support, to protect where t ... Read More
Casual apparel is a Western dress code that is relaxed, occasional, spontaneous and suited for ... Read More